KATRD International Conference 2021

Invited Speakers

Luncheon Symposium 01
Airway Disease
- Which Types of Asthma Patients Would Benefit from Omalizumab?
  Marc Humbert ERS President, Paris-Saclay University
  France CV
Luncheon Symposium 02
Interstitial Lung Disease
- Antifibrotic Therapy in Japan: Long Term Treatment Experience of Pirfenidone
  Hirofumi Chiba Sapporo Medical University
  Japan CV
Luncheon Symposium 03
Lung Cancer
- Transform Treatment Strategy for EGFRm NSCLC Patients from Early to Advanced Stage
  In-Jae Oh Chonnam National University
  Korea CV
Luncheon Symposium 04
Airway Disease
- Therapeutic Index of Inhaled Corticosteroids
  Dave Singh University of Manchester
  UK CV
Luncheon Symposium 05
Lung Cancer
- Up-to-date NSCLC Treatment, LECLAZA^®: The Hopes of the Patients
  Seong Hoon Yoon Pusan National University
  Korea CV
Luncheon Symposium 06
Airway Disease
- History of GOLD – What Has Been the Main Focus?
  Jadwiga Anna Wedzicha National Heart and Lung Institute
  UK CV